Substance-Use Disorders in Children and Adolescents.
Journal
Deutsches Arzteblatt international
ISSN: 1866-0452
Titre abrégé: Dtsch Arztebl Int
Pays: Germany
ID NLM: 101475967
Informations de publication
Date de publication:
24 06 2022
24 06 2022
Historique:
received:
27
05
2021
revised:
27
05
2021
accepted:
25
01
2022
pubmed:
1
6
2022
medline:
5
10
2022
entrez:
31
5
2022
Statut:
ppublish
Résumé
The most common substance use disorders in childhood and adolescence have to do with alcohol and cannabis. These disorders begin as early as puberty, are often accompanied by other mental disorders, and, if untreated, very frequently persist into adulthood. This review is based on pertinent publications retrieved by a selective search in PubMed on substance use disorders in children and adolescents. Substance use disorders are among the commonest mental disorders in childhood and adolescence. In Germany, approximately 10% of adolescents have tried cannabis at least once. The prognosis is negatively affected by individual (bio-)psychological traits, mental comorbidities, laws that facilitate consumption, socioeconomic disadvantage, consuming peers, and parental substance use disorders. A timely diagnosis, motivation by the pediatrician, and referral to specialized child and adolescent psychiatric services helps assure that those affected receive appropriate treatment, with the goal of abstinence from the substance as well as improvement in emotional regulation, affectivity, and attention. According to studies from the English-speaking countries and considering all treatment forms, treatment is completed by approximately 60% to 65% of children and adolescents; 20% to 40% of these patients are abstinent six months after the end of treatment. No studies of this type have been carried out to date in Germany. As the results of treatment are generally poor, there is a major need for research on the treatment and care of children and adolescents with substance use disorders. In particular, the interfaces between outpatient and inpatient care need further improvement.
Sections du résumé
BACKGROUND
The most common substance use disorders in childhood and adolescence have to do with alcohol and cannabis. These disorders begin as early as puberty, are often accompanied by other mental disorders, and, if untreated, very frequently persist into adulthood.
METHODS
This review is based on pertinent publications retrieved by a selective search in PubMed on substance use disorders in children and adolescents.
RESULTS
Substance use disorders are among the commonest mental disorders in childhood and adolescence. In Germany, approximately 10% of adolescents have tried cannabis at least once. The prognosis is negatively affected by individual (bio-)psychological traits, mental comorbidities, laws that facilitate consumption, socioeconomic disadvantage, consuming peers, and parental substance use disorders. A timely diagnosis, motivation by the pediatrician, and referral to specialized child and adolescent psychiatric services helps assure that those affected receive appropriate treatment, with the goal of abstinence from the substance as well as improvement in emotional regulation, affectivity, and attention. According to studies from the English-speaking countries and considering all treatment forms, treatment is completed by approximately 60% to 65% of children and adolescents; 20% to 40% of these patients are abstinent six months after the end of treatment. No studies of this type have been carried out to date in Germany.
CONCLUSION
As the results of treatment are generally poor, there is a major need for research on the treatment and care of children and adolescents with substance use disorders. In particular, the interfaces between outpatient and inpatient care need further improvement.
Identifiants
pubmed: 35635442
pii: arztebl.m2022.0122
doi: 10.3238/arztebl.m2022.0122
pmc: PMC9549893
doi:
pii:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
440-450Références
Eur J Psychotraumatol. 2017 Mar 31;8(1):1304114
pubmed: 28451071
Z Kinder Jugendpsychiatr Psychother. 2016;44(4):295-303; quiz 304-5
pubmed: 27434689
J Clin Child Adolesc Psychol. 2014;43(5):695-720
pubmed: 24926870
Drug Alcohol Depend. 2010 Aug 1;110(3):247-53
pubmed: 20456872
Z Kinder Jugendpsychiatr Psychother. 2021 Nov;49(6):486-493
pubmed: 32795136
Drug Alcohol Rev. 2007 Jan;26(1):33-9
pubmed: 17364834
Dtsch Arztebl Int. 2015 Apr 17;112(16):271-8
pubmed: 25939318
Pharmacol Biochem Behav. 2020 May;192:172906
pubmed: 32179028
Lancet. 2011 Jun 18;377(9783):2093-102
pubmed: 21652063
Z Kinder Jugendpsychiatr Psychother. 2019 Mar;47(2):103-110
pubmed: 30727819
Subst Use Misuse. 1998 Nov;33(13):2561-604
pubmed: 9818990
Eur Neuropsychopharmacol. 2020 Jul;36:169-180
pubmed: 32268974
Pediatr Clin North Am. 2002 Apr;49(2):329-43
pubmed: 11993286
J Abnorm Child Psychol. 1996 Aug;24(4):499-512
pubmed: 8886945
Psychol Rev. 1993 Oct;100(4):674-701
pubmed: 8255953
Curr Opin Psychiatry. 2021 Jul 1;34(4):393-399
pubmed: 33993169
Lancet. 2004 May 15;363(9421):1579-88
pubmed: 15145631
Drug Test Anal. 2014 Jan-Feb;6(1-2):39-45
pubmed: 23836598
Neuropsychol Rev. 2016 Jun;26(2):186-222
pubmed: 27125202
Lancet. 2007 Jul 28;370(9584):319-28
pubmed: 17662880
Addict Biol. 2017 Nov;22(6):1778-1789
pubmed: 27578457
Dtsch Arztebl Int. 2009 May;106(19):323-8
pubmed: 19547732
J Am Acad Child Adolesc Psychiatry. 1999 Jun;38(6):693-9
pubmed: 10361787
Dev Psychopathol. 2001 Spring;13(2):355-75
pubmed: 11393651
Lancet. 2016 Jun 11;387(10036):2383-401
pubmed: 27174305
J Am Acad Child Adolesc Psychiatry. 2016 Apr;55(4):280-8
pubmed: 27015718
J Nerv Ment Dis. 1986 Nov;174(11):669-79
pubmed: 3772356
Addiction. 2013 Jan;108(1):124-33
pubmed: 22775447
J Affect Disord. 2015 Jan 15;171:39-47
pubmed: 25285897
Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2693-8
pubmed: 21262822
Int J Methods Psychiatr Res. 2008 Jun;17 Suppl 1:S16-29
pubmed: 18543359
Z Kinder Jugendpsychiatr Psychother. 2020 Nov;48(6):448-452
pubmed: 32208050
Cochrane Database Syst Rev. 2016 May 05;(5):CD005336
pubmed: 27149547
Eur Arch Psychiatry Clin Neurosci. 2020 Jun;270(4):403-412
pubmed: 31563981
Psychol Med. 2021 Feb;51(3):353-364
pubmed: 33536109
J Am Acad Child Adolesc Psychiatry. 2005 Jun;44(6):609-21
pubmed: 15908844
Drug Alcohol Depend. 2011 May 1;115(1-2):120-30
pubmed: 21145178
Neuropsychopharmacology. 2015 Jan;40(1):61-87
pubmed: 24938210
Arch Gen Psychiatry. 2012 Apr;69(4):372-80
pubmed: 22147808
JAMA Psychiatry. 2019 Apr 1;76(4):426-434
pubmed: 30758486
Alcohol Clin Exp Res. 2015 Nov;39(11):2234-48
pubmed: 26463560
J Clin Child Adolesc Psychol. 2018 Jul-Aug;47(4):499-526
pubmed: 29893607
Eur Neuropsychopharmacol. 2012 Apr;22(4):267-80
pubmed: 21865014
Eur Addict Res. 2020;26(4-5):223-232
pubmed: 32634814
N Engl J Med. 2014 Jun 5;370(23):2219-27
pubmed: 24897085
Lancet Psychiatry. 2020 Apr;7(4):344-353
pubmed: 32197092
Z Kinder Jugendpsychiatr Psychother. 2018 Mar;46(2):173-181
pubmed: 29521187
J Clin Child Adolesc Psychol. 2021 Jul-Aug;50(4):498-509
pubmed: 32716211
JAMA Netw Open. 2021 Oct 1;4(10):e2130280
pubmed: 34668942
J Adolesc Health. 2004 Oct;35(4):321-8
pubmed: 15450546
JAMA Psychiatry. 2015 Aug;72(8):757-66
pubmed: 26039070